Added Value of Contrast-enhanced Ultrasound for BI RADS 4A Nodules

Second Affiliated Hospital, School of Medicine, Zhejiang University500 enrolled

Overview

The aim of this study was to investigate the added value of contrast-enhanced ultrasound (CEUS) for differentiating low risk patients with breast nodules categorized as 4A using the Breast Imaging Reporting and Data System (BI-RADS). The study included patients with 4A nodules confirmed by core biopsy and/or surgery. The CEUS parameters were assessed to evaluated the added value in BI-RADS 4A nodules

Study Type

OBSERVATIONAL

Enrollment

500

Conditions

Ultrasound Breast Cancer Pathology

Eligibility

Sex: ALLMin age: 18 YearsMax age: 80 Years

Medical Language ↔ Plain English

Inclusion Criteria: patients with nodules which were sonographically classified as BI-RADS 4 A breast lesion Exclusion Criteria: (i) absence of a pathologic diagnosis; (ii) presence of breast nodules that were too large to compare with normal parenchyma; (iii) patients with radiotherapy and chemotherapy of breast cancer; and (iv) skin disorders.

Locations (1)

SAHZJU

Hanzhou, Zhejiang, China

RECRUITING

Outcomes

Primary Outcomes

CEUS

if the result of CEUS is positive，the nodule was downgraded. if the result of CEUS is negative, the nodule was kept as BI RADS 4A category. Then all nodules were submitted to biopsy or surgery.

Time frame: up to 3 months

Central Contacts

zimei Lin

CONTACT

15157171799 kelaidia@163.com

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.